$AMWL

HIRSCHHORN MARK sold $105K of AMWL

HIRSCHHORN MARK (Chief Financial Officer) sold 10,761 shares of American Well Corp (AMWL) at $9.74 ($0.10M total) on 2026-06-01.

Original reporting
SEC EDGAR · HIRSCHHORN MARK
Published Jun 3, 2026, 9:01 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 3, 2026, 9:07 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AMWL
Neutral
medium confidence
Mentioned
$AMWL
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMWLNeutralLow
01

Why it matters

The disclosure updates ownership information but does not introduce new operational or financial guidance.

02

Market read

Traders may monitor AMWL for follow-on insider activity, but the filing alone is unlikely to drive a major repricing.

03

What to watch

The article doesn’t state whether other insiders bought/sold, nor does it provide context for the CFO’s compensation or tax obligations.

Relevance 6/10Novelty 5/10Timing: Filed June 3, covering a sale executed June 1.

Background

This is an SEC Form 4 insider transaction disclosure for American Well Corp.

Company-level read

Ticker impact

$AMWLNeutralMedium confidence
Context

AMWL CFO Mark Hirschhorn sold 10,761 shares in an open-market transaction disclosed via SEC Form 4.

Expected impact

Limited near-term impact; any effect is likely sentiment-driven and small versus fundamentals.

Evidence & confidence

Form 4 insider sales are common and the filing notes no 10b5-1 plan, but the article lacks any linkage to earnings, guidance, or operational events.

Market effects

No clear sector read-through; this is company-specific insider activity.

None indicated.

None indicated.

Counterpoint

The sale may reflect diversification, taxes, or routine liquidity needs rather than a bearish view.

Key entities

  • AMWL

    American Well Corp; subject of the insider sale disclosure.

  • HIRSCHHORN MARK

    Chief Financial Officer who sold shares via an open-market transaction.

Related articles

$QTTBMedAI 8/10

Top Biotech Gainers: QTTB Sends Strong SIGNAL; AMWL And SI In Focus

Biotech gainers highlighted Q32 Bio (QTTB), up 90.7% to $21.38 after positive Phase 2 SIGNAL-AA results for bempikibart in alopecia areata, and it launched a $200M underwritten stock offering. Agenus (AGEN) rose 82.7% to $6.12 on a planned ~$85M private placement for BOT+BAL Phase 3 ROBBIN1. Other movers: ACTU, GALT, AMWL, SI.